# King Pharmaceuticals LLC - Inspection Records

Source: https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5

> Inspection records and compliance data for King Pharmaceuticals LLC in Rochester, Michigan. Access full analysis and detailed observations.

---

## Details

- Name: King Pharmaceuticals LLC
- FEI Number: 1876582
- Canada Business Number: 814881744
- City: Rochester
- State: Michigan
- Country Name: United States
- Address Line 1: 1200 Parkdale Rd
- Zip Code: 48307
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - King Pharmaceuticals LLC - 2025-02-18](https://www.keypedia.com/records/483/king-pharmaceuticals-llc/0b1a81a9-74c5-4125-9ef6-34fc1bcd7429) — source: FDA, date: February 18, 2025
- [483 - King Pharmaceuticals LLC - 2025-02-18](https://www.keypedia.com/records/483/king-pharmaceuticals-llc/9e7a48a4-3559-425d-9cad-9d60f62c3a43) — source: FDA, date: February 18, 2025
- [FDA Inspection 1261579 - King Pharmaceuticals LLC - 2025-02-18](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/e5c72c4e-54fe-4484-bed9-03e7d9adb0d4) — classification: Official Action Indicated (OAI), source: FDA, date: February 18, 2025
- [483 - King Pharmaceuticals LLC - 2019-10-21](https://www.keypedia.com/records/483/king-pharmaceuticals-llc/589209b1-870a-4c6a-8718-de4e70e013db) — source: FDA, date: October 21, 2019
- [FDA Inspection 1107986 - King Pharmaceuticals LLC - 2019-10-21](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/58f418d8-9ca1-4be2-855a-7bc1a490a62d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 21, 2019
- [FDA Inspection 1049269 - King Pharmaceuticals LLC - 2018-03-14](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/1740ba12-7cee-4499-b95b-a614494a8f93) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2018
- [FDA Inspection 1000037 - King Pharmaceuticals LLC - 2016-11-21](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/59536aff-e7e2-4946-95f5-65e155fc801b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2016
- [FDA Inspection 926523 - King Pharmaceuticals LLC - 2015-05-15](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/4bc99bb3-adf2-4e83-a761-5401e8d9ef2c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 15, 2015
- [FDA Inspection 892667 - King Pharmaceuticals LLC - 2014-08-26](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/347aea7a-3f84-4348-96af-67e02cca1cc4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2014
- [FDA Inspection 807158 - King Pharmaceuticals LLC - 2012-12-13](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/3c7b4bcb-ac1d-48b3-bb5a-0fb4657b5643) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2012
- [FDA Inspection 786574 - King Pharmaceuticals LLC - 2012-06-15](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/4c1de0ec-f665-43b9-ae67-4c0c3cbe8959) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 15, 2012
- [FDA Inspection 713757 - King Pharmaceuticals LLC - 2011-03-16](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/6a50e321-51c5-4502-b50c-9f41d1bdca03) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 16, 2011
- [FDA Inspection 638769 - King Pharmaceuticals LLC - 2010-01-19](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/6d18c07e-39c1-4d09-b4ca-4c7f5290b6d3) — classification: Official Action Indicated (OAI), source: FDA, date: January 19, 2010

## Related Companies

- [Med-Pharmex, Inc.](https://www.keypedia.com/companies/med-pharmex-inc/fc3eae98-cbb3-4470-89f2-ef8f616f0a87)
- [C. B. Fleet Company, Inc.](https://www.keypedia.com/companies/c-b-fleet-company-inc/f5f5e7fa-8113-4539-bab4-a153edd37d6a)
- [Allergan Pharmaceuticals Ireland](https://www.keypedia.com/companies/allergan-pharmaceuticals-ireland/b65756b6-b7d5-438c-a312-93abdd3b372d)
- [Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company](https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)
- [AMO (Hangzhou) Co., Ltd.](https://www.keypedia.com/companies/amo-hangzhou-co-ltd/00c065f6-3b50-4050-811e-d03ad3d646e9)
- [WES Pharma Inc.](https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d)
- [Laboratorios Liconsa SAU](https://www.keypedia.com/companies/laboratorios-liconsa-sau/ab88a2bb-8c52-445d-8417-82ea8f48bdf6)
- [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e)

## Related Officers

- [Alan M. Roberts](https://www.keypedia.com/people/alan-m-roberts/b6565c30-6228-4f51-a1b7-369bffe54e9c)
- [Associate Director](https://www.keypedia.com/people/jeffrey-d-meng/55543677-bd74-4cc5-8a2a-e14afb91d338)
- [Joohi Castelvetere](https://www.keypedia.com/people/joohi-castelvetere/2340bef8-5105-4f40-9713-120196b70d82)
- [Nicholas J. Presto](https://www.keypedia.com/people/nicholas-j-presto/2ecdd573-6662-4d07-b93c-ddb9c603bcfa)
- [Investigator](https://www.keypedia.com/people/jacob-g-lutz/ca2710c6-064f-4728-9129-aad73e74f12d)